Association of Herpesvirus and Periodontitis (HerPerio)

November 21, 2022 updated by: Miguel de Araújo Nobre

Association of Herpesvirus and Periodontitis: A Clinical and Laboratorial Case-control Study

A significant influence of the Herpes viruses family in the progression of periodontal disease has been suggested. The aim of this study was to investigate the potential association of four Herpes viruses (HSV-1, HSV-2, CMV and EBV) with periodontal disease using a qualitative test for evaluating the presence or absence of viral DNA in crevicular fluid samples of both healthy periodontal patients and periodontal compromised patients.

Adult patients with healthy periodontium or periodontally compromised attending the Egas Moniz university dental clinic (Almada, Portugal) are eligible to participate The study involves a periodontal diagnosis and collection of unstimulated crevicular fluid from saliva samples.

There will be no direct benefits for patients, but indirect benefit of advancing science in the study of potential involvment of Herpes viruses in periodontitis. No risks of participating are antecipated as the study material and data will be anonymized.

The study runs from the the Cooperativa de Ensino Egas Moniz and is expected to run for 3 months.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lisbon, Portugal, 1600-042
        • Malo Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients (> 18 years of age) with natural teeth present attending clinical appointments at the Egas Moniz university dental clinic.

Description

Inclusion Criteria:

  • Patients (> 18 years of age) with natural teeth attending clinical appointments at the Egas Moniz university dental clinic;
  • Cases (periodontally compromised) included at the Department of Periodontology of the same clinic;
  • Controls (periodontally healthy) included at the remaining departments of the same clinic.

Exclusion Criteria:

  • Occurrence of a viral infection during the six months prior to the clinical study;
  • Exposure to antiviral medication in the six months prior to the survey;
  • Clinical history of immunosuppression, either exogenous or endogenous;
  • Chemotherapy in the previous six months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cases
Periodontally compromised patients attending the Periodontology Department during periodontal diagnosis appointments at the point of first diagnosis.
Unstimulated crevicular fluid samples are collected using two sized 35 paper cones per subject, both used in the sampling process. The DNA is extracted from the samples through multiplex PCR at the Egas Moniz Applied Microbiology Laboratory (LMAEM).
Controls
Periodontally healthy patients attending the remaining specialty departments ath the same clinic at the point of first diagnosis.
Unstimulated crevicular fluid samples are collected using two sized 35 paper cones per subject, both used in the sampling process. The DNA is extracted from the samples through multiplex PCR at the Egas Moniz Applied Microbiology Laboratory (LMAEM).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The presence of virus DNA (HSV1, HSV2, EBV and CMV)
Time Frame: 1 day
The presence of virus DNA (HSV1, HSV2, EBV and CMV)
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking
Time Frame: one year
[Smoking] (smoker, non-smoker) measured through questionnaire at first appointment;
one year
Alcohol consumption
Time Frame: one year
[Alcohol consumption] (yes, no) measured through questionnaire at first appointment;
one year
Oral hygiene habits
Time Frame: one year
[Oral hygiene habits] (0-1 times per day, 1-2 times per day and 2-3 times per day) measured through questionnaire at first time appointment.
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Miguel A de Araújo Nobre, PhD, Malo Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Actual)

July 31, 2019

Study Completion (Actual)

February 1, 2022

Study Registration Dates

First Submitted

November 21, 2022

First Submitted That Met QC Criteria

November 21, 2022

First Posted (Actual)

November 30, 2022

Study Record Updates

Last Update Posted (Actual)

November 30, 2022

Last Update Submitted That Met QC Criteria

November 21, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HerPerio

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

he datasets generated during and/or analysed during the current study will be available upon reasonable request.

IPD Sharing Time Frame

8 years

IPD Sharing Access Criteria

Upon reasonable request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Sampe collection

Subscribe